News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Wyeth (WYE) To Present At The SG Cowen & Co., LLC 25th Annual Healthcare Conference


10/19/2005 5:13:00 PM

MADISON, N.J., March 11 /PRNewswire-FirstCall/ -- Wyeth announced today that it will present at the SG Cowen & Co. 25th Annual Healthcare Conference on March 15, 2005 at 8:50 a.m. Eastern Time. Presenting for Wyeth will be Joseph S. Camardo, M.D., Senior Vice President, Global Medical Affairs, Wyeth Research.

Wyeth's presentation will be webcast live for investors at http://www.wyeth.com/ and available for replay following the conference.

Wyeth is one of the world's largest research-driven pharmaceutical and health care products companies. It is a leader in the discovery, development, manufacturing, and marketing of pharmaceuticals, vaccines, biotechnology products, and non-prescription medicines that improve the quality of life for people worldwide. The Company's major divisions include Wyeth Pharmaceuticals, Wyeth Consumer Healthcare, and Fort Dodge Animal Health.

The statements in this press release that are not historical facts are forward-looking statements based on current expectations of future events that involve risks and uncertainties including, without limitation, risks associated with the inherent uncertainty of the timing and success of pharmaceutical research, product development, manufacturing, commercialization, economic conditions including interest and currency exchange rate fluctuations, changes in generally accepted accounting principles, the impact of competitive or generic products, trade buying patterns, wars or terrorist acts, product liability and other types of lawsuits, the impact of legislation and regulatory compliance and obtaining reimbursement, favorable drug pricing, access and other approvals, environmental liabilities, and patent, and other risks and uncertainties, including those detailed from time to time in the Company's periodic reports, including current reports on Form 8-K, quarterly reports on Form 10-Q and the annual report on Form 10-K, filed with the Securities and Exchange Commission. Actual results may vary materially from the forward-looking statements. The Company assumes no obligation to publicly update any forward-looking statements, whether as a result of new information, future events or otherwise.

Wyeth

CONTACT: Media: Lowell Weiner, +1-973-660-5013, or Investor: JustinVictoria, +1-973-660-5340, both of Wyeth


Read at BioSpace.com

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES